%0 Journal Article
%T Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma
%A Joel M. Mor
%A Ludwig M. Heindl
%J Archive of "Ocular Oncology and Pathology".
%D 2017
%R 10.1159/000452473
%X In this review, we outline similarities between conjunctival and skin melanoma as well as the effectiveness of combined BRAF/MEK inhibition in melanoma, and discuss the applicability of these agents in conjunctival melanoma
%K Conjunctival melanoma
%K BRAF inhibitor
%K MEK inhibitor
%K Primary acquired melanosis
%K Metastatic disease
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566756/